These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36936521)

  • 1. Evaluation of Natural Bioactive-Derived Punicalagin Niosomes in Skin-Aging Processes Accelerated by Oxidant and Ultraviolet Radiation [Retraction].
    Drug Des Devel Ther; 2023; 17():807-808. PubMed ID: 36936521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Natural Bioactive-Derived Punicalagin Niosomes in Skin-Aging Processes Accelerated by Oxidant and Ultraviolet Radiation.
    Mohamad EA; Aly AA; Khalaf AA; Ahmed MI; Kamel RM; Abdelnaby SM; Abdelzaher YH; Sedrak MG; Mousa SA
    Drug Des Devel Ther; 2021; 15():3151-3162. PubMed ID: 34321865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro Preparation and Evaluation of Sustained-Release Microcapsules of Salvianolic Acid [Retraction].
    Drug Des Devel Ther; 2021; 15():5133-5134. PubMed ID: 34992349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Tetrandrine-Loaded Chitosan Microsphere: Characterization and in vivo Evaluation [Retraction].
    Drug Des Devel Ther; 2022; 16():4015-4016. PubMed ID: 36425304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Ocular Delivery of Brinzolamide Based on Gellan Gum: In vitro and in vivo Evaluation [Retraction].
    Drug Des Devel Ther; 2022; 16():4109-4110. PubMed ID: 36483460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Nanoliposomal Formulation of Erlotinib for Lung Cancer and in vitro/In vivo Antitumoral Evaluation [Retraction].
    Drug Des Devel Ther; 2022; 16():4019-4020. PubMed ID: 36425305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Evaluation of in-situ Nasal Gel Formulations of Nanosized Transferosomal Sumatriptan: Design, Optimization, in vitro and in vivo Evaluation [Retraction].
    Drug Des Devel Ther; 2022; 16():2291-2292. PubMed ID: 35875674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in vitro/vivo Evaluation [Retraction].
    Drug Des Devel Ther; 2022; 16():4013-4014. PubMed ID: 36425307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, in vitro and in vivo Evaluation of Thermosensitive in situ Gel Loaded with Ibuprofen-Solid Lipid Nanoparticles for Rectal Delivery [Retraction].
    Drug Des Devel Ther; 2022; 16():3445-3446. PubMed ID: 36238197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Purine Thioglycoside Analogs: Synthesis, Nanoformulation and Biological Evaluation in in vitro Human Liver and Breast Cancer Models [Retraction].
    Drug Des Devel Ther; 2022; 16():2289-2290. PubMed ID: 35875676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Bispecific Immunotoxin Delivered by Human Bone Marrow-Derived Mesenchymal Stem Cells to Target Blood Vessels and Vasculogenic Mimicry of Malignant Gliomas [Retraction].
    Drug Des Devel Ther; 2021; 15():3733-3734. PubMed ID: 34511882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ammonium Glycyrrhizinate-Loaded Niosomes as a Potential Nanotherapeutic System for Anti-Inflammatory Activity in Murine Models [Retraction].
    Int J Nanomedicine; 2022; 17():3403-3404. PubMed ID: 35945927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of Novel Pirfenidone Microspheres for Lung-Targeted Delivery: In vitro and in vivo Study [Retraction].
    Drug Des Devel Ther; 2022; 16():4017-4018. PubMed ID: 36425306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cinobufagin Suppresses the Characteristics of Osteosarcoma Cancer Cells by Inhibiting the IL-6-OPN-STAT3 Pathway [Retraction].
    Drug Des Devel Ther; 2021; 15():4445-4446. PubMed ID: 34737550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin Decreases Insulin Resistance in Type 1 Diabetes Through Regulating P53 and RAP2A in vitro and in vivo [Retraction].
    Drug Des Devel Ther; 2021; 15():2431. PubMed ID: 34135572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginkgolide B Ameliorates Myocardial Ischemia Reperfusion Injury in Rats via Inhibiting Endoplasmic Reticulum Stress [Retraction].
    Drug Des Devel Ther; 2020; 14():4131. PubMed ID: 33116401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Effects of Tyroserleutide on Lung Metastasis of Human Hepatocellular Carcinoma SK-HEP-1 and Its Mechanism Affecting ICAM-1 and MMP-2 and -9 [Retraction].
    Drug Des Devel Ther; 2023; 17():647-648. PubMed ID: 36879927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cordycepin Alleviates Anterior Cruciate Ligament Transection (ACLT)-Induced Knee Osteoarthritis Through Regulating TGF-β Activity and Autophagy [Retraction].
    Drug Des Devel Ther; 2020; 14():4133. PubMed ID: 33116402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senkyunolide A Protects Neural Cells against Corticosterone-Induced Apoptosis by Modulating Protein Phosphatase 2A and α-Synuclein Signaling [Retraction].
    Drug Des Devel Ther; 2022; 16():2187-2188. PubMed ID: 35855740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Apoptosis and Autophagy via sirtuin1- and PI3K/Akt/mTOR-Mediated Pathways by Plumbagin in Human Prostate Cancer Cells [Retraction].
    Drug Des Devel Ther; 2022; 16():2437-2438. PubMed ID: 35937567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.